Sangamo Therapeutics
Utility Patent Applications
Last updated:
List of all Sangamo Therapeutics patents 63 in total
| Status | Patent |
|---|---|
Application | Utility: METHODS AND COMPOSITIONS FOR THE TREATMENT OF FABRY DISEASE Filling date: 8 Sep 2025 Issue date: 1 Sep 2022 |
Application | Utility: METHODS AND COMPOSITIONS FOR MODIFICATION OF HLA Filling date: 8 Sep 2025 Issue date: 30 Jun 2022 |
Application | Utility: TARGETED DISRUPTION OF THE MHC CELL RECEPTOR Filling date: 8 Sep 2025 Issue date: 9 Jun 2022 |
Application | Utility: ENGINEERED CLEAVAGE HALF-DOMAINS Filling date: 8 Sep 2025 Issue date: 12 May 2022 |
Application | Utility: HTT REPRESSORS AND USES THEREOF Filling date: 8 Sep 2025 Issue date: 3 Mar 2022 |
Application | Utility: HTT REPRESSORS AND USES THEREOF Filling date: 8 Sep 2025 Issue date: 2 Dec 2021 |
Application | Utility: NUCLEASE-MEDIATED REGULATION OF GENE EXPRESSION Filling date: 8 Sep 2025 Issue date: 11 Nov 2021 |
Application | Utility: PROGRAMMED CELL DEATH 1 (PD1) SPECIFIC NUCLEASES Filling date: 8 Sep 2025 Issue date: 14 Oct 2021 |
Application | Utility: TARGETED TREATMENT OF LEBER CONGENITAL AMOUROSIS Filling date: 8 Sep 2025 Issue date: 22 Jul 2021 |
Application | Utility: METHODS AND COMPOSITIONS FOR REGULATION OF TRANSGENE EXPRESSION Filling date: 8 Sep 2025 Issue date: 24 Jun 2021 |
Application | Utility: METHODS AND COMPOSITIONS FOR GENOME ENGINEERING Filling date: 8 Sep 2025 Issue date: 24 Jun 2021 |
Application | Utility: IMPROVED CLINICAL PARAMETERS BY EXPRESSION OF FACTOR VIII Filling date: 8 Sep 2025 Issue date: 10 Jun 2021 |
Application | Utility: GIN RECOMBINASE VARIANTS Filling date: 8 Sep 2025 Issue date: 6 May 2021 |
Application | Utility: METHOD OF INACTIVATING A GLUCOCORTICOID RECEPTOR GENE IN AN ISOLATED CELL Filling date: 8 Sep 2025 Issue date: 8 Apr 2021 |
Application | Utility: METHODS AND COMPOSITIONS FOR TREATING HUNTINGTON'S DISEASE Filling date: 8 Sep 2025 Issue date: 4 Mar 2021 |
Application | Utility: MODULATION OF LIVER GENES Filling date: 8 Sep 2025 Issue date: 4 Mar 2021 |
Application | Utility: METHODS AND COMPOSITIONS FOR MODIFICATION OF A HLA LOCUS Filling date: 8 Sep 2025 Issue date: 25 Feb 2021 |
Application | Utility: ENGINEERED TARGET SPECIFIC NUCLEASES Filling date: 8 Sep 2025 Issue date: 28 Jan 2021 |
Application | Utility: ENGINEERED TARGET SPECIFIC NUCLEASES Filling date: 8 Sep 2025 Issue date: 28 Jan 2021 |
Application | Utility: NUCLEASE-MEDIATED REGULATION OF GENE EXPRESSION Filling date: 8 Sep 2025 Issue date: 28 Jan 2021 |
Application | Utility: COMPOSITIONS FOR LINKING DNA-BINDING DOMAINS AND CLEAVAGE DOMAINS Filling date: 8 Sep 2025 Issue date: 14 Jan 2021 |
Application | Utility: Separation and Quantification of Empty and Full Viral Capsid Particles Filling date: 8 Sep 2025 Issue date: 14 Jan 2021 |
Application | Utility: GENETIC MODIFICATION OF MITOCHONDRIAL GENOMES Filling date: 8 Sep 2025 Issue date: 7 Jan 2021 |
Application | Utility: Controlled Transgene Expression in Regulatory T Cells Filling date: 8 Sep 2025 Issue date: 26 Nov 2020 |
Application | Utility: ENGINEERING AAV Filling date: 8 Sep 2025 Issue date: 26 Nov 2020 |
Application | Utility: ENGINEERED TARGET SPECIFIC NUCLEASES Filling date: 8 Sep 2025 Issue date: 29 Oct 2020 |
Application | Utility: Modulators of Chromosome 9 Open Reading Frame 72 Gene Expression and Uses Thereof Filling date: 8 Sep 2025 Issue date: 29 Oct 2020 |
Application | Utility: COMPOSITIONS FOR LINKING DNA-BINDING DOMAINS AND CLEAVAGE DOMAINS Filling date: 8 Sep 2025 Issue date: 8 Oct 2020 |
Application | Utility: METHODS AND COMPOSITIONS FOR INCREASING RNA ACTIVITY IN A CELL Filling date: 8 Sep 2025 Issue date: 8 Oct 2020 |
Application | Utility: METHOD FOR THE TREATMENT OF BETA-THALASSEMIA Filling date: 8 Sep 2025 Issue date: 8 Oct 2020 |
Application | Utility: METHODS AND COMPOSITIONS FOR TARGETED CLEAVAGE AND RECOMBINATION Filling date: 8 Sep 2025 Issue date: 24 Sep 2020 |
Application | Utility: TARGETED DELETION OF CELLULAR DNA SEQUENCES Filling date: 8 Sep 2025 Issue date: 17 Sep 2020 |
Application | Utility: METHODS AND COMPOSITIONS FOR ENGINEERING IMMUNITY Filling date: 8 Sep 2025 Issue date: 10 Sep 2020 |
Application | Utility: COMPOSITIONS AND METHODS FOR PRODUCING RECOMBINANT AAV Filling date: 8 Sep 2025 Issue date: 10 Sep 2020 |
Application | Utility: METHODS AND COMPOSITIONS FOR TARGETED SINGLE-STRANDED CLEAVAGE AND TARGETED INTEGRATION Filling date: 8 Sep 2025 Issue date: 3 Sep 2020 |
Application | Utility: METHOD FOR THE TREATMENT OF MUCOPOLYSACCHARIDOSIS TYPE I Filling date: 8 Sep 2025 Issue date: 6 Aug 2020 |
Application | Utility: METHODS AND COMPOSITIONS FOR THE TREATMENT OF FABRY DISEASE Filling date: 8 Sep 2025 Issue date: 30 Jul 2020 |
Application | Utility: METHODS AND COMPOSITIONS FOR THE TREATMENT OF LYSOSOMAL STORAGE DISEASES Filling date: 8 Sep 2025 Issue date: 23 Jul 2020 |
Application | Utility: ENGINEERED CLEAVAGE HALF-DOMAINS Filling date: 8 Sep 2025 Issue date: 23 Jul 2020 |
Application | Utility: REGULATION OF GENE EXPRESSION USING ENGINEERED NUCLEASES Filling date: 8 Sep 2025 Issue date: 30 Apr 2020 |
Application | Utility: ENGINEERED GENETIC MODULATORS Filling date: 8 Sep 2025 Issue date: 9 Apr 2020 |
Application | Utility: METHODS AND COMPOSITIONS FOR MODULATION OF TAU PROTEINS Filling date: 8 Sep 2025 Issue date: 2 Apr 2020 |
Application | Utility: DELIVERY METHODS AND COMPOSITIONS FOR NUCLEASE-MEDIATED GENOME ENGINEERING Filling date: 8 Sep 2025 Issue date: 2 Apr 2020 |
Application | Utility: FAD3 PERFORMANCE LOCI AND CORRESPONDING TARGET SITE SPECIFIC BINDING PROTEINS CAPABLE OF INDUCING TARGETED BREAKS Filling date: 8 Sep 2025 Issue date: 19 Mar 2020 |
Application | Utility: METHODS AND COMPOSITIONS FOR MODIFICATION OF A CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR (CFTR) GENE Filling date: 8 Sep 2025 Issue date: 12 Mar 2020 |
Application | Utility: TARGETED DISRUPTION OF THE MHC CELL RECEPTOR Filling date: 8 Sep 2025 Issue date: 5 Mar 2020 |
Application | Utility: METHODS AND COMPOSITIONS FOR INTEGRATION OF AN EXOGENOUS SEQUENCE WITHIN THE GENOME OF PLANTS Filling date: 8 Sep 2025 Issue date: 5 Mar 2020 |
Application | Utility: ENZYMATIC ASSAYS FOR QUANTIFYING THERAPY IN SUBJECTS WITH MUCOPOLYSACCHARIDOSIS TYPE I OR II Filling date: 8 Sep 2025 Issue date: 5 Mar 2020 |
Application | Utility: ENGINEERED TARGET SPECIFIC BASE EDITORS Filling date: 8 Sep 2025 Issue date: 27 Feb 2020 |
Application | Utility: METHOD FOR THE TREATMENT OF MUCOPOLYSACCHARIDOSIS TYPE II Filling date: 8 Sep 2025 Issue date: 27 Feb 2020 |
Showing 1 to 50 of 63 patents.